{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T11:56:48Z","timestamp":1794743808505,"version":"4.9.1"},"reference-count":129,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["E2A-23-1148250"],"award-info":[{"award-number":["E2A-23-1148250"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PRIN20225R4Y5"],"award-info":[{"award-number":["PRIN20225R4Y5"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN2022943TH9"],"award-info":[{"award-number":["PRIN2022943TH9"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"Horizon 2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["D11_PNRR_CN3_S3_2"],"award-info":[{"award-number":["D11_PNRR_CN3_S3_2"]}],"id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007625","name":"Cure Alzheimer's Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.neuropharm.2026.110876","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T17:10:39Z","timestamp":1770657039000},"page":"110876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The neuronal P2X7R controversy: Revisiting evidence, methods, and unresolved questions"],"prefix":"10.1016","volume":"289","author":[{"given":"Neha","family":"Kachappilly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6077-3265","authenticated-orcid":false,"given":"Paola","family":"Pizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emy","family":"Basso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.110876_bib1","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1096\/fj.09-153601","article-title":"Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor","volume":"24","author":"Adinolfi","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2026.110876_bib2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.bcp.2017.12.021","article-title":"The P2X7 receptor: a main player in inflammation","volume":"151","author":"Adinolfi","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110876_bib3","series-title":"Cutting Edge: a Natural P451L Mutation in the Cytoplasmic Domain Impairs the Function of the Mouse P2X7 Receptor1","author":"Adriouch","year":"2002"},{"key":"10.1016\/j.neuropharm.2026.110876_bib4","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1016\/j.febslet.2008.10.041","article-title":"Functional evidence for presynaptic P2X7 receptors in adult rat cerebrocortical nerve terminals","volume":"582","author":"Alloisio","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2026.110876_bib5","doi-asserted-by":"crossref","first-page":"14556","DOI":"10.1074\/jbc.M115.642033","article-title":"Contribution of the juxtatransmembrane intracellular regions to the time course and permeation of ATP-gated P2X7 receptor ion channels","volume":"290","author":"Allsopp","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2026.110876_bib6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbi.2024.05.023","article-title":"Opposing effects of the purinergic P2X7 receptor on seizures in neurons and microglia in male mice","volume":"120","author":"Alves","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2026.110876_bib7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.tins.2006.03.003","article-title":"Emerging challenges of assigning P2X7 receptor function and immunoreactivity in neurons","volume":"29","author":"Anderson","year":"2006","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110876_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.00124","article-title":"The P2X7 receptor: central hub of brain diseases","volume":"13","author":"Andrejew","year":"2020","journal-title":"Front. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110876_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-13300-8","article-title":"The loss of P2X7 receptor expression leads to increase intestinal glucose transit and hepatic steatosis","volume":"7","author":"Arguin","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2026.110876_bib10","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.neuroscience.2003.08.065","article-title":"Differential co-localisation of the P2X7 receptor subunit with vesicular glutamate transporters VGLUT1 and VGLUT2 in rat CNS","volume":"123","author":"Atkinson","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2026.110876_bib11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/epi.13263","article-title":"Up-regulation of P2X7 receptor\u2013mediated inhibition of GABA uptake by nerve terminals of the human epileptic neocortex","volume":"57","author":"Barros-Barbosa","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2026.110876_bib12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neuroscience.2015.08.026","article-title":"P2X7 receptor activation downmodulates Na+-dependent high-affinity GABA and glutamate transport into rat brain cortex synaptosomes","volume":"306","author":"Barros-Barbosa","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2026.110876_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neuint.2017.11.005","article-title":"Under stressful conditions activation of the ionotropic P2X7 receptor differentially regulates GABA and glutamate release from nerve terminals of the rat cerebral cortex","volume":"112","author":"Barros-Barbosa","year":"2018","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2026.110876_bib14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bbr.2008.10.018","article-title":"Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: relevance for neuropsychiatric disorders","volume":"198","author":"Basso","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2026.110876_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2017.00021","article-title":"The ATP-gated P2X7 receptor as a target for the treatment of drug-resistant epilepsy","author":"Beamer","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110876_bib16","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1111\/bph.15785","article-title":"Increased expression of the ATP-gated P2X7 receptor reduces responsiveness to anti-convulsants during status epilepticus in mice","volume":"179","author":"Beamer","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.110876_bib17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11064-025-04502-y","article-title":"The multifaceted role of P2X7R in Microglia and astrocytes","volume":"50","author":"Bedetta","year":"2025","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2026.110876_bib18","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/bph.12314","article-title":"Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567","volume":"170","author":"Bhattacharya","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110876_bib19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0014-2999(99)00350-7","article-title":"Pharmacological characterization of recombinant human and rat P2X receptor subtypes","volume":"376","author":"Bianchi","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110876_bib20","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1523\/JNEUROSCI.2235-12.2013","article-title":"P2X7 receptor channels allow direct permeation of nanometer-sized dyes","volume":"33","author":"Browne","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110876_bib21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1113\/expphysiol.2013.071951","article-title":"Purinergic signalling: from discovery to current developments","volume":"99","author":"Burnstock","year":"2013","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.neuropharm.2026.110876_bib22","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3390\/ph17101291","article-title":"Pharmacology of P2X receptors and their possible therapeutic potential in obesity and diabetes","volume":"17","author":"Cabral-Garc\u00eda","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.neuropharm.2026.110876_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.566251","article-title":"P2X7 receptor-dependent layer-specific changes in neuron-microglia reactivity in the prefrontal cortex of a phencyclidine induced mouse model of schizophrenia","volume":"13","author":"Calovi","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110876_bib24","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.neuint.2012.02.034","article-title":"Calmidazolium selectively inhibits exocytotic glutamate release evoked by P2X7 receptor activation","volume":"60","author":"Cervetto","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2026.110876_bib25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bbrc.2005.04.087","article-title":"Identification and characterization of splice variants of the human P2X7 ATP channel","volume":"332","author":"Cheewatrakoolpong","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2026.110876_bib26","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.pain.2005.01.002","article-title":"Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain","volume":"114","author":"Chessell","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2026.110876_bib27","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/WNR.0b013e32833d9142","article-title":"P2X7 receptors enhance glutamate release in hippocampal hilar neurons","volume":"21","author":"Cho","year":"2010","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2026.110876_bib28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/B978-0-444-63380-4.00002-0","article-title":"P2X7 antagonists as potential therapeutic agents for the treatment of CNS disorders","volume":"53","author":"Chrovian","year":"2014","journal-title":"Prog. Med. Chem."},{"key":"10.1016\/j.neuropharm.2026.110876_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066547","article-title":"Neurochemical changes in the mouse hippocampus underlying the antidepressant effect of genetic deletion of P2X7 receptors","volume":"8","author":"Cs\u00f6lle","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2026.110876_bib30","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pnpbp.2017.11.003","article-title":"The P2RX7 polymorphism rs2230912 is associated with depression: a meta-analysis","volume":"82","author":"Czamara","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.110876_bib31","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.neuint.2010.07.009","article-title":"AMPA- and P2X7-receptor-mediated facilitation of [3H]d-aspartate release from nerve terminals isolated from the rat caudal brainstem","volume":"57","author":"D'Amico","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2026.110876_bib32","doi-asserted-by":"crossref","first-page":"8174","DOI":"10.3390\/ijms23158174","article-title":"Alternatively spliced isoforms of the P2X7 receptor: structure, function and disease associations","volume":"23","author":"De Salis","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.110876_bib33","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.1523\/JNEUROSCI.21-18-07143.2001","article-title":"Neuronal P2X7 receptors are targeted to presynaptic terminals in the central and peripheral nervous systems","volume":"21","author":"Deuchars","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110876_bib34","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/onc.2016.206","article-title":"Extracellular purines, purinergic receptors and tumor growth","volume":"36","author":"Di Virgilio","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.neuropharm.2026.110876_bib35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.immuni.2017.06.020","article-title":"The P2X7 receptor in infection and inflammation","volume":"47","author":"Di Virgilio","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.neuropharm.2026.110876_bib36","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1242\/jcs.034082","article-title":"Inhibition of the ATP-gated P2X7 receptor promotes axonal growth and branching in cultured hippocampal neurons","volume":"121","author":"D\u00edaz-Hernandez","year":"2008","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.neuropharm.2026.110876_bib37","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1476-5381.2009.00233.x","article-title":"Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors","volume":"157","author":"Donnelly-Roberts","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110876_bib38","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.neuropharm.2008.06.012","article-title":"[3H]A-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors","volume":"56","author":"Donnelly-Roberts","year":"2009","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.neuropharm.2026.110876_bib39","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1523\/JNEUROSCI.23-04-01320.2003","article-title":"P2X7 receptor-mediated release of excitatory amino acids from astrocytes","volume":"23","author":"Duan","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110876_bib40","article-title":"A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37","author":"Elssner","year":"2004","journal-title":"Induces IL-1 Processing and Release1"},{"key":"10.1016\/j.neuropharm.2026.110876_bib41","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1096\/fj.11-196089","article-title":"Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice","volume":"26","author":"Engel","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2026.110876_bib42","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ceb.2008.09.008","article-title":"The cell biology of neural stem and progenitor cells and its significance for their proliferation versus differentiation during mammalian brain development","volume":"20","author":"Farkas","year":"2008","journal-title":"Curr. Opin. Cell Biol."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.110876_bib43","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/glia.22707","article-title":"Astrocyte\u2013neuron interaction in the substantia gelatinosa of the spinal cord dorsal horn via P2X7 receptor\u2010mediated release of glutamate and reactive oxygen species","volume":"62","author":"Ficker","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2026.110876_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156468","article-title":"Critical evaluation of P2X7 receptor antagonists in selected seizure models","volume":"11","author":"Fischer","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2026.110876_bib45","first-page":"1000","article-title":"Antibody landscapes after influenza virus infection or vaccination","volume":"346","author":"Fowler","year":"2014","journal-title":"Science (1979)"},{"key":"10.1016\/j.neuropharm.2026.110876_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.793769","article-title":"Detection and functional evaluation of the P2X7 receptor in hiPSC derived neurons and microglia-like cells","volume":"14","author":"Francistiov\u00e1","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110876_bib47","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jneumeth.2015.09.011","article-title":"Combined electrophysiological and biosensor approaches to study purinergic regulation of epileptiform activity in cortical tissue","volume":"260","author":"Frenguelli","year":"2016","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2026.110876_bib48","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1097\/WNR.0000000000001136","article-title":"The effects of P2X7 receptor knockout on emotional conditions over the lifespan of mice","volume":"29","author":"Gao","year":"2018","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2026.110876_bib49","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/bs.pmch.2019.11.002","article-title":"P2X7 receptor antagonists for the treatment of systemic inflammatory disorders","volume":"59","author":"Gelin","year":"2020","journal-title":"Prog. Med. Chem."},{"key":"10.1016\/j.neuropharm.2026.110876_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096281","article-title":"Modulation of Mouse Embryonic stem cell proliferation and neural differentiation by the P2X7 receptor","volume":"9","author":"Glaser","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2026.110876_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109284","article-title":"P2X7 receptor inhibition alleviates mania-like behavior independently of interleukin-1\u03b2","volume":"27","author":"G\u00f6l\u00f6ncs\u00e9r","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.neuropharm.2026.110876_bib52","author":"Grassi"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110876_bib53","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s12035-014-9031-z","article-title":"Role of P2X7 receptor in an animal model of Mania induced by D-Amphetamine","volume":"53","author":"Gubert","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.110876_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.910662","article-title":"Mesial Temporal lobe epilepsy (MTLE) drug-refractoriness is associated with P2X7 receptors overexpression in the human hippocampus and temporal neocortex and may be predicted by low circulating levels of miR-22","volume":"16","author":"Guerra Leal","year":"2022","journal-title":"Front. Cell. Neurosci."},{"issue":"11","key":"10.1016\/j.neuropharm.2026.110876_bib55","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s00726-020-02912-6","article-title":"Proteomic comparison of different synaptosome preparation procedures","volume":"52","author":"Guly\u00e1ssy","year":"2020","journal-title":"Amino Acids"},{"key":"10.1016\/j.neuropharm.2026.110876_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fnsyn.2023.1130198","article-title":"Bringing synapses into focus: recent advances in synaptic imaging and mass-spectrometry for studying synaptopathy","volume":"15","author":"Hindley","year":"2023","journal-title":"Front. Synaptic Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110876_bib57","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12031-017-0968-z","article-title":"Inhibition of P2X7 receptor ameliorates nuclear factor-kappa B mediated neuroinflammation induced by status epilepticus in rat hippocampus","volume":"63","author":"Huang","year":"2017","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110876_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2021.101993","article-title":"The potential of the P2X7 receptor as a therapeutic target in a sub-chronic PCP-induced rodent model of schizophrenia","volume":"116","author":"Huang","year":"2021","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.neuropharm.2026.110876_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107560","article-title":"P2X7 purinergic receptor modulates dentate gyrus excitatory neurotransmission and alleviates schizophrenia-like symptoms in mouse","volume":"26","author":"Huang","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.neuropharm.2026.110876_bib60","doi-asserted-by":"crossref","first-page":"7049","DOI":"10.1523\/JNEUROSCI.3103-16.2017","article-title":"Neuronal P2X7 receptors revisited: do they really exist?","volume":"37","author":"Illes","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110876_bib61","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/bph.15299","article-title":"Update of P2X receptor properties and their pharmacology: IUPHAR review 30","volume":"178","author":"Illes","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110876_bib62","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.neuroscience.2004.06.014","article-title":"P2X 7-like receptor subunits enhance excitatory synaptic transmission at central synapses by presynaptic mechanisms","volume":"128","author":"Ireland","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2026.110876_bib63","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1523\/JNEUROSCI.4009-15.2016","article-title":"Transient P2X7 receptor antagonism produces lasting reductions in spontaneous seizures and gliosis in experimental temporal lobe epilepsy","volume":"36","author":"Jimenez-Pacheco","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110876_bib64","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1111\/epi.12257","article-title":"Increased neocortical expression of the P2X7 receptor after status epilepticus and anticonvulsant effect of P2X7 receptor antagonist A-438079","volume":"54","author":"Jimenez-Pacheco","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2026.110876_bib65","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1124\/mol.110.070276","article-title":"Inhibition of neuronal voltage-gated sodium channels by brilliant blue G","volume":"80","author":"Jo","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110876_bib66","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/stcltm\/szae074","article-title":"Exploring P2X7 receptor antagonism as a therapeutic target for neuroprotection in an hiPSC motor neuron model","volume":"13","author":"Johns","year":"2024","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.neuropharm.2026.110876_bib67","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.36217","article-title":"Re-evaluation of neuronal P2X7 expression using novel mouse models and a P2X7-specific nanobody","volume":"7","author":"Kaczmarek-Hajek","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.neuropharm.2026.110876_bib68","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.22153","article-title":"Structural basis for subtype-specific inhibition of the P2X7 receptor","volume":"5","author":"Karasawa","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.neuropharm.2026.110876_bib69","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00887-9","article-title":"Structural insights into the competitive inhibition of the ATP-gated P2X receptor channel","volume":"8","author":"Kasuya","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2026.110876_bib70","article-title":"P2X7 receptor antagonism suppresses epileptiform-like activity in an inflammation-primed human iPSC-derived neuron model of drug-resistant epilepsy","author":"Kesavan","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110876_bib71","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.brainresbull.2018.07.016","article-title":"Astrocytic rather than neuronal P2X7 receptors modulate the function of the tri-synaptic network in the rodent hippocampus","volume":"151","author":"Khan","year":"2019","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2026.110876_bib72","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/glia.22615","article-title":"Regulation of activity of P2X7 receptor by its splice variants in cultured mouse astrocytes","volume":"62","author":"Kido","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2026.110876_bib73","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1172\/JCI44818","article-title":"The P2X7 receptor\u2013pannexin-1 complex decreases muscarinic acetylcholine receptor\u2013mediated seizure susceptibility in mice","volume":"121","author":"Kim","year":"2011","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuropharm.2026.110876_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2019.00183","article-title":"P2X7 interactions and signaling \u2013 making head or tail of it","volume":"12","author":"Kopp","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110876_bib75","doi-asserted-by":"crossref","DOI":"10.1038\/srep36680","article-title":"The role of P2X7 receptors in a rodent PCP-induced schizophrenia model","volume":"6","author":"Kov\u00e1nyi","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2026.110876_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.conb.2023.102685","article-title":"How astrocytic ATP shapes neuronal activity and brain circuits","volume":"79","author":"Lezmy","year":"2023","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.110876_bib77","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ejphar.2015.09.026","article-title":"A novel radioligand for the ATP-gated ion channel P2X7: [3H] JNJ-54232334","volume":"765","author":"Lord","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110876_bib78","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1111\/j.1471-4159.2008.05322.x","article-title":"P2X7 pre-synaptic receptors in adult rat cerebrocortical nerve terminals: a role in ATP-induced glutamate release","volume":"105","author":"Marcoli","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2026.110876_bib79","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.neuroscience.2007.10.038","article-title":"Synaptic terminals from mice midbrain exhibit functional P2X7 receptor","volume":"151","author":"Mar\u00edn-Garc\u00eda","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2026.110876_bib80","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1476-5381.2011.01624.x","article-title":"Expression, assembly and function of novel C-terminal truncated variants of the mouse P2X7 receptor: re-evaluation of P2X7 knockouts","volume":"165","author":"Masin","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110876_bib81","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.cell.2019.09.017","article-title":"Full-length P2X7 structures reveal how palmitoylation prevents channel desensitization","volume":"179","author":"McCarthy","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2026.110876_bib82","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neuropharm.2013.05.017","article-title":"P2X7 receptors at adult neural progenitor cells of the mouse subventricular zone","volume":"73","author":"Messemer","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.110876_bib83","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11302-016-9546-z","article-title":"Genetically dissecting P2rx7 expression within the central nervous system using conditional humanized mice","volume":"13","author":"Metzger","year":"2017","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.neuropharm.2026.110876_bib84","doi-asserted-by":"crossref","first-page":"11688","DOI":"10.1523\/JNEUROSCI.3487-16.2017","article-title":"Heterozygosity for the mood disorder-associated variant Gln460Arg alters P2X7 receptor function and sleep quality","volume":"37","author":"Metzger","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110876_bib85","author":"Miras-Portugal"},{"key":"10.1016\/j.neuropharm.2026.110876_bib86","doi-asserted-by":"crossref","first-page":"7063","DOI":"10.1523\/JNEUROSCI.3104-16.2017","article-title":"Neuronal P2X7 receptor: involvement in neuronal physiology and pathology","volume":"37","author":"Miras-Portugal","year":"2017","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110876_bib87","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/npp.2011.181","article-title":"From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment","volume":"37","author":"Moghaddam","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.110876_bib88","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1007\/s12264-020-00573-9","article-title":"Characterization of the expression of the ATP-gated P2X7 receptor following status epilepticus and during epilepsy using a P2X7-EGFP reporter mouse","volume":"36","author":"Morgan","year":"2020","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.neuropharm.2026.110876_bib89","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41401-025-01638-z","article-title":"NADPH acts as an endogenous P2X7 receptor modulator to gate neuroinflammatory responses of microglia","volume":"47","author":"Mou","year":"2026","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuropharm.2026.110876_bib90","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0167-4889(94)90200-3","article-title":"Macrophages loaded with doxorubicin by ATP-mediated permeabilization: potential carriers for antitumor therapy","volume":"1224","author":"Munerati","year":"1994","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"issue":"11","key":"10.1016\/j.neuropharm.2026.110876_bib91","doi-asserted-by":"crossref","first-page":"8199","DOI":"10.1016\/S0021-9258(18)53082-9","article-title":"Oxidized ATP an irreversible inhibitor of the macrophage purinergic P2Z receptor","volume":"268","author":"Murgia","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2026.110876_bib92","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1523\/JNEUROSCI.0805-22.2022","article-title":"Dual role of the P2X7 receptor in dendritic outgrowth during physiological and pathological brain development","volume":"43","author":"Mut-Arbona","year":"2023","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110876_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109541","article-title":"P2 receptor-mediated signaling in the physiological and pathological brain: from development to aging and disease","volume":"233","author":"Mut-Arbona","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.110876_bib94","doi-asserted-by":"crossref","first-page":"25813","DOI":"10.1074\/jbc.M109.033134","article-title":"A functional P2X7 splice variant with an alternative transmembrane domain 1 escapes gene inactivation in P2X7 knock-out mice","volume":"284","author":"Nicke","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2026.110876_bib95","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.4049\/jimmunol.1002843","article-title":"Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-Sensitive pathway","volume":"186","author":"Niemi","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.neuropharm.2026.110876_bib96","series-title":"Molecular Physiology of P2X Receptors","first-page":"1013","author":"North","year":"2002"},{"key":"10.1016\/j.neuropharm.2026.110876_bib97","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/ijnp\/pyx046","article-title":"P2X7 receptors drive spine synapse plasticity in the learned helplessness model of depression","volume":"20","author":"Otrokocsi","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2026.110876_bib98","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1097\/00001756-200410250-00017","article-title":"Lack of ATP-evoked GABA and glutamate release in the hippocampus of P2X7 receptor-\/- mice","volume":"15","author":"Papp","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2026.110876_bib99","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1474-4422(10)70310-0","article-title":"Mechanisms of epileptogenesis and potential treatment targets","volume":"10","author":"Pitk\u00e4nen","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2026.110876_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-76428-0","article-title":"Deviant reporter expression and P2X4 passenger gene overexpression in the soluble EGFP BAC transgenic P2X7 reporter mouse model","volume":"10","author":"Ram\u00edrez-Fern\u00e1ndez","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2026.110876_bib101","doi-asserted-by":"crossref","first-page":"17514","DOI":"10.1074\/jbc.M109.053082","article-title":"C-terminal calmodulin-binding motif differentially controls human and rat P2X7 receptor current facilitation","volume":"285","author":"Roger","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2026.110876_bib102","first-page":"3568","article-title":"Pilocarpine-induced status epilepticus increases the sensitivity of P2X7 and P2Y1 receptors to nucleotides at neural progenitor cells of the juvenile rodent hippocampus","volume":"27","author":"Rozmer","year":"2017","journal-title":"Cerebr. Cortex"},{"issue":"10","key":"10.1016\/j.neuropharm.2026.110876_bib103","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00210-014-1005-1","article-title":"Functional P2X7 receptors at cultured hippocampal astrocytes but not neurons","volume":"387","author":"Rubini","year":"2014","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.neuropharm.2026.110876_bib104","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1016\/j.febslet.2005.05.073","article-title":"Characterization of a functional P2X7-like receptor in cerebellar granule neurons from P2X7 knockout mice","volume":"579","author":"S\u00e1nchez-Nogueiro","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2026.110876_bib105","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.4049\/jimmunol.0803612","article-title":"Activation of microglia by amyloid \u03b2 requires P2X7 receptor expression","volume":"182","author":"Sanz","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.neuropharm.2026.110876_bib106","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S1074-7613(03)00266-8","article-title":"NAD-induced T cell death: ADP-ribosylation of cell surface proteins by ART2 activates the cytolytic P2X7 purinoceptor","volume":"19","author":"Seman","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.neuropharm.2026.110876_bib107","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1523\/JNEUROSCI.1469-04.2004","article-title":"Reanalysis of P2X7 receptor expression in rodent brain","volume":"24","author":"Sim","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110876_bib108","series-title":"The P2X7 Receptor","first-page":"17","author":"Sluyter","year":"2017"},{"key":"10.1016\/j.neuropharm.2026.110876_bib109","doi-asserted-by":"crossref","first-page":"8225","DOI":"10.3390\/ijms24098225","article-title":"Animal models for the investigation of P2X7 receptors","volume":"24","author":"Sluyter","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.110876_bib110","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1074\/jbc.M006781200","article-title":"Altered cytokine production in mice lacking P2X7Receptors","volume":"276","author":"Solle","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2026.110876_bib111","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.tips.2014.08.002","article-title":"P2X7 receptor: an emerging target in central nervous system diseases","volume":"35","author":"Sperl\u00e1gh","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2026.110876_bib129","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1046\/j.1471-4159.2002.00920.x","article-title":"Involvement of P2X7 receptors in the regulation of neurotransmitter release in the rat hippocampus","volume":"81","author":"Sperl\u00e1gh","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuropharm.2026.110876_bib112","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.7150\/thno.100365","article-title":"Hippocampal P2X7 and A2A purinoceptors mediate cognitive impairment caused by long-lasting epileptic seizures","volume":"15","author":"Sun","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.neuropharm.2026.110876_bib113","first-page":"735","article-title":"The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7)","volume":"272","author":"Surprenant","year":"1996","journal-title":"Science (1979)"},{"key":"10.1016\/j.neuropharm.2026.110876_bib114","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/637986","article-title":"Association between P2X7 receptor polymorphisms and bone status in mice","volume":"2012","author":"Syberg","year":"2012","journal-title":"J. Osteoporos."},{"key":"10.1016\/j.neuropharm.2026.110876_bib115","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1189\/jlb.0408251","article-title":"Lymphocytes from P2X7-deficient mice exhibit enhanced P2X7 responses","volume":"85","author":"Taylor","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.neuropharm.2026.110876_bib116","doi-asserted-by":"crossref","first-page":"E688","DOI":"10.1210\/jc.2014-4160","article-title":"Variation in glucose homeostasis traits associated with P2RX7 polymorphisms in mice and humans","volume":"100","author":"Todd","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neuropharm.2026.110876_bib117","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bbi.2021.02.012","article-title":"Brain immune cells characterization in UCMS exposed P2X7 knock-out mouse","volume":"94","author":"Troubat","year":"2021","journal-title":"Brain Behav. Immun."},{"issue":"8","key":"10.1016\/j.neuropharm.2026.110876_bib118","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.274","article-title":"PKC-dependent ERK phosphorylation is essential for P2X7 receptor-mediated neuronal differentiation of neural progenitor cells","volume":"4","author":"Tsao","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2026.110876_bib119","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/pcn.12823","article-title":"Glutamate hypothesis in schizophrenia","volume":"73","author":"Uno","year":"2019","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110876_bib120","article-title":"P2X7 receptor-related genetic mouse models \u2013 tools for translational research in psychiatry","volume":"16","author":"Urbina-Trevi\u00f1o","year":"2022","journal-title":"Front. Neural Circ."},{"key":"10.1016\/j.neuropharm.2026.110876_bib121","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0028-3908(97)00141-X","article-title":"Effects of divalent cations, protons and calmidazolium at the rat P2X7 receptor","volume":"36","author":"Virginio","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.110876_bib122","first-page":"1","article-title":"Establishment and behavioural characterization of a novel constitutive P2X7 receptor knockout mouse line","author":"von M\u00fccke-Heim","year":"2025","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.neuropharm.2026.110876_bib123","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/j.1471-4159.2005.03465.x","article-title":"Supersensitivity of P2X7 receptors in cerebrocortical cell cultures after in-vitro ischemia","volume":"95","author":"Wirkner","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2026.110876_bib124","first-page":"3776","article-title":"Splice variants of the P2X7 receptor reveal differential agonist dependence and functional coupling with pannexin-1","volume":"125","author":"Xu","year":"2012","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.neuropharm.2026.110876_bib125","doi-asserted-by":"crossref","first-page":"14213","DOI":"10.1523\/JNEUROSCI.2390-10.2010","article-title":"Experimental characterization and mathematical modeling of P2X7 receptor channel gating","volume":"30","author":"Yan","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110876_bib126","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1124\/mol.106.030163","article-title":"Amino acid residues in the P2X7 receptor that mediate differential sensitivity to ATP and BzATP","volume":"71","author":"Young","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110876_bib127","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/cns.12663","article-title":"Neonatal maternal deprivation enhances presynaptic P2X7 receptor transmission in Insular cortex in an adult rat model of visceral hypersensitivity","volume":"23","author":"Zhang","year":"2017","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2026.110876_bib128","article-title":"ATP indirectly stimulates hippocampal CA1 and CA3 pyramidal neurons via the activation of neighboring P2X7 receptor-bearing astrocytes and NG2 glial cells, respectively","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826000493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826000493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T07:58:36Z","timestamp":1779004716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826000493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":129,"alternative-id":["S0028390826000493"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110876","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The neuronal P2X7R controversy: Revisiting evidence, methods, and unresolved questions","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110876","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110876"}}